The use of artificial intelligence and natural language processing for mental health interventions

Natural Language Processing (NLP) to examine mental health interventions (MHI).

PharmaDrug’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – May 15, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on

May 15, 2024

EMA CHMP issues positive opinion for AstraZeneca’s Soliris

AstraZeneca’s Soliris initially obtained approval in the EU in 2017 to treat adults. Credit: AstraZeneca. The European Medicines Agency’s committee for medicinal products for human

June 27, 2023

AMA Issues 7 Principles for AI Development, Deployment, and Use

What You Should Know: – The American Medical Association (AMA) today released seven new principles for augmented intelligence (AI) development, deployment, and use, marking a

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.